Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.30
Delayed Data
As of May 22
 -0.30 / -0.69%
Today’s Change
37.20
Today|||52-Week Range
45.58
+12.44%
Year-to-Date
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
May 22 / Zacks.com - Paid Partner Content
Ionis (IONS) Stock Falls Despite Positive Inotersen Data
May 16 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications
May 19 / Zacks.com - Paid Partner Content
Mylan (MYL) Beats on Q1 Earnings, Revenues Miss Estimates
May 10 / Zacks.com - Paid Partner Content
Hikma Trims Full Year Revenue Guidance After Advair Diskus Delay
May 19 / TheStreet.com - Paid Partner Content
Epizyme (EPZM) Incurs Narrower-than-Expected Loss in Q1
May 09 / Zacks.com - Paid Partner Content
Huge Downgrades Loom Over Hikma Pharmaceuticals
May 17 / TheStreet.com - Paid Partner Content